ECS secures Australian supply agreements worth $11.9m
|
26 June 2023 at 9:50am
|
Trading Halt
|
23 June 2023 at 9:35am
|
Market Update
|
21 June 2023 at 10:20am
|
Change of Director's Interest Notice
|
16 June 2023 at 10:00am
|
Change of Director's Interest Notice
|
14 June 2023 at 2:20pm
|
ECS Launches Investor Hub
|
13 June 2023 at 2:20pm
|
Change of Director's Interest Notice
|
6 June 2023 at 9:35am
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
26 April 2023 at 8:40am
|
HY Report - Strategy Drives Record Financial Performance
|
28 February 2023 at 10:20am
|
Half Yearly Report and Accounts
|
28 February 2023 at 10:15am
|
Management Change
|
10 February 2023 at 9:40am
|
Monthly Activities/Appendix 4C Cash Flow Report
|
16 January 2023 at 10:25am
|
ECS Secures $9.9m Supply Agreement into Germany
|
4 January 2023 at 8:45am
|
New Product & Market Update
|
20 December 2022 at 9:20am
|
Change of Director's Interest Notice
|
10 November 2022 at 8:35am
|
Victorian Flood Update
|
7 November 2022 at 8:50am
|
Sale Completion of Tasmanian Assets
|
4 November 2022 at 8:50am
|
Change of Director's Interest Notice X3
|
4 November 2022 at 8:45am
|
Notification regarding unquoted securities - ECS
|
4 November 2022 at 8:40am
|
Notification of cessation of securities - ECS
|
4 November 2022 at 8:40am
|
Constitution
|
28 October 2022 at 3:10pm
|
Results of Annual General Meeting
|
26 October 2022 at 3:40pm
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
26 October 2022 at 9:20am
|
Sale of Tasmanian Assets
|
24 October 2022 at 9:05am
|
AGM Letter to Shareholders
|
23 September 2022 at 8:35am
|
Notice of Annual General Meeting/Proxy Form
|
23 September 2022 at 8:35am
|
Appendix 4G and Corporate Governance Statement
|
23 September 2022 at 8:35am
|
Annual Report to shareholders
|
23 September 2022 at 8:35am
|
Appendix 4E Preliminary Final Report
|
1 September 2022 at 8:50am
|
AGM Date and Closing Date for Director Nominations
|
26 August 2022 at 1:20pm
|
Office of Drug Control Approves Expansion
|
22 August 2022 at 9:30am
|
Notification regarding unquoted securities - ECS
|
16 August 2022 at 10:25am
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
25 July 2022 at 9:59am
|
Non-dilutive funding and asset sale update
|
22 July 2022 at 8:50am
|
Investor Presentation
|
6 July 2022 at 9:30am
|
ECS Exports First Shipment to New Zealand
|
4 July 2022 at 9:25am
|
Change of Director's Interest Notice
|
27 June 2022 at 11:35am
|
Focussed Strategy to Maximise Growth
|
14 June 2022 at 9:35am
|
Final Director's Interest Notice
|
14 June 2022 at 8:45am
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
26 April 2022 at 10:05am
|
Change of Director's Interest Notice
|
5 April 2022 at 8:50am
|
Marketing, Operational & Revenue Update
|
8 March 2022 at 10:25am
|
HY Report - Increasing Sales Drives Revenue Growth
|
23 February 2022 at 10:10am
|
Half Yearly Report and Accounts
|
23 February 2022 at 9:59am
|
ECS delivers first shipment to the United Kingdom
|
14 February 2022 at 8:45am
|
Change in substantial holding
|
2 February 2022 at 10:55am
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 January 2022 at 10:20am
|
Change of Director's Interest Notice X4
|
14 January 2022 at 7:45pm
|
Secondary Trading Notice
|
14 January 2022 at 7:40pm
|
ECSO Top 20 Holders
|
14 January 2022 at 7:40pm
|